• S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

  • May 7 2021
  • Length: 25 mins
  • Podcast
S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit By cover art

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Listen for free

View show details

  • Summary

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.
    Show more Show less
Show more Show less

What listeners say about S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available